Supplementary Table S2 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer

<p>Evidence for ctDNA estimates per patient per timepoint</p>

Сохранить в:

Библиографические подробности
Главный автор:	Sofie H. Tolmeijer (15313251) (author)
Другие авторы:	Emmy Boerrigter (15313254) (author), Takayuki Sumiyoshi (15034119) (author), Edmond M. Kwan (15313257) (author), Sarah W.S. Ng (14960841) (author), Matti Annala (15313260) (author), Gráinne Donnellan (15313263) (author), Cameron Herberts (14960820) (author), Guillemette E. Benoist (15313266) (author), Paul Hamberg (15313269) (author), Diederik M. Somford (15035198) (author), Inge M. van Oort (15035171) (author), Jack A. Schalken (15313272) (author), Niven Mehra (15011036) (author), Nielka P. van Erp (15313275) (author), Alexander W. Wyatt (14960922) (author)
Опубликовано:	2025
Предметы:	Cancer Cancer Detection and Diagnosis Methods and Technology Biomarkers Circulating tumor cells/DNA/exosomes Genitourinary Cancers Prostate cancer Liquid Biopsy
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!

Схожие документы